BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37058251)

  • 21. The oncologic outcome and prognostic factors for solitary colorectal liver metastasis after liver resection.
    Hsu YJ; Chern YJ; Wu ZE; Yu YL; Liao CK; Tsai WS; You JF; Lee CW
    J Gastrointest Surg; 2024 Mar; 28(3):267-275. PubMed ID: 38445919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preoperative Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and CEA as the Potential Prognostic Biomarkers for Colorectal Cancer.
    Ming-Sheng F; Mei-Ling D; Xun-Quan C; Yuan-Xin H; Wei-Jie Z; Qin-Cong P
    Can J Gastroenterol Hepatol; 2022; 2022():3109165. PubMed ID: 35028301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of the Naples prognostic score in colorectal cancer patients undergoing curative resection: a propensity score matching analysis.
    Sugimoto A; Fukuoka T; Shibutani M; Kasashima H; Kitayama K; Ohira M; Maeda K
    BMC Gastroenterol; 2023 Mar; 23(1):88. PubMed ID: 36966294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical significance of preoperative neutrophil-lymphocyte versus platelet-lymphocyte ratio in patients with operable colorectal cancer.
    Kwon HC; Kim SH; Oh SY; Lee S; Lee JH; Choi HJ; Park KJ; Roh MS; Kim SG; Kim HJ; Lee JH
    Biomarkers; 2012 May; 17(3):216-22. PubMed ID: 22424597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Role of Cancer-Elicited Inflammatory Biomarkers in Predicting Early Recurrence Within Stage II-III Colorectal Cancer Patients After Curable Resection.
    Ying HQ; Liao YC; Sun F; Peng HX; Cheng XX
    J Inflamm Res; 2021; 14():115-129. PubMed ID: 33500648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of Hematologic and Other Prognostic Markers in Metastatic Colorectal Cancer.
    Mercier J; Voutsadakis IA
    J Gastrointest Cancer; 2019 Sep; 50(3):493-506. PubMed ID: 29704170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prognostic value of preoperative NLR, d-NLR, PLR and LMR for predicting clinical outcome in surgical colorectal cancer patients.
    Ying HQ; Deng QW; He BS; Pan YQ; Wang F; Sun HL; Chen J; Liu X; Wang SK
    Med Oncol; 2014 Dec; 31(12):305. PubMed ID: 25355641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The MIMIC Study: Prognostic Role and Cutoff Definition of Monocyte-to-Lymphocyte Ratio and Lactate Dehydrogenase Levels in Metastatic Colorectal Cancer.
    Basile D; Garattini SK; Corvaja C; Montico M; Cortiula F; Pelizzari G; Gerratana L; Audisio M; Lisanti C; Fanotto V; Ongaro E; Iacono D; Cardellino GG; Foltran L; Pella N; Buonadonna A; Aprile G; Di Maio M; Fasola G; Puglisi F
    Oncologist; 2020 Aug; 25(8):661-668. PubMed ID: 32202020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systemic Immune-Inflammation Index Predicts Tumor Recurrence after Radical Resection for Colorectal Cancer.
    Nakamoto S; Ohtani Y; Sakamoto I; Hosoda A; Ihara A; Naitoh T
    Tohoku J Exp Med; 2023 Nov; 261(3):229-238. PubMed ID: 37673651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postoperative chemotherapy is associated with prognosis of stage IV colorectal cancer treated with preoperative chemotherapy/chemoradiotherapy and curative resection.
    Nozawa H; Sonoda H; Ishii H; Emoto S; Murono K; Kaneko M; Sasaki K; Nishikawa T; Shuno Y; Tanaka T; Kawai K; Hata K; Ishihara S
    Int J Colorectal Dis; 2020 Jan; 35(1):177-180. PubMed ID: 31807855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Propensity score analysis of recurrence for neutrophil-to-lymphocyte ratio in colorectal cancer.
    Balde AI; Fang S; He L; Cai Z; Han S; Wang W; Li Z; Kang L
    J Surg Res; 2017 Nov; 219():244-252. PubMed ID: 29078889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict chemotherapy outcomes and prognosis in patients with colorectal cancer and synchronous liver metastasis.
    Wu Y; Li C; Zhao J; Yang L; Liu F; Zheng H; Wang Z; Xu Y
    World J Surg Oncol; 2016 Nov; 14(1):289. PubMed ID: 27852294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preoperative Neutrophil-BMI Ratio As a Promising New Marker for Predicting Tumor Outcomes in Colorectal Cancer.
    Xie W; Huang X; Wei C; Mo X; Ru H; Zhang L; Ge L; Tang W; Liu J
    Technol Cancer Res Treat; 2022; 21():15330338211064077. PubMed ID: 35225701
    [No Abstract]   [Full Text] [Related]  

  • 34. Blood cholesterol-to-lymphocyte ratio as a novel prognostic marker to predict postoperative overall survival in patients with colorectal cancer.
    Zhou S; He Q; Sheng N; Gong J; Ren J; Wang Z
    World J Surg Oncol; 2022 Jan; 20(1):18. PubMed ID: 35033097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CONUT: a novel independent predictive score for colorectal cancer patients undergoing potentially curative resection.
    Tokunaga R; Sakamoto Y; Nakagawa S; Ohuchi M; Izumi D; Kosumi K; Taki K; Higashi T; Miyamoto Y; Yoshida N; Oki E; Watanabe M; Baba H
    Int J Colorectal Dis; 2017 Jan; 32(1):99-106. PubMed ID: 27726014
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Significance of the 7th postoperative day neutrophil-to-lymphocyte ratio in colorectal cancer.
    Hayama T; Hashiguchi Y; Okada Y; Ono K; Nemoto K; Shimada R; Ozawa T; Toyoda T; Tsuchiya T; Iinuma H; Nozawa K; Matsuda K
    Int J Colorectal Dis; 2020 Jan; 35(1):119-124. PubMed ID: 31797097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inflammation-based prognostic scores as indicators to select candidates for primary site resection followed by multimodal therapy among colorectal cancer patients with multiple metastases.
    Shimura T; Toiyama Y; Saigusa S; Imaoka H; Okigami M; Fujikawa H; Hiro J; Kobayashi M; Ohi M; Araki T; Inoue Y; Uchida K; Mohri Y; Kusunoki M
    Int J Clin Oncol; 2017 Aug; 22(4):758-766. PubMed ID: 28299463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postoperative, but not preoperative, inflammation-based prognostic markers are prognostic factors in stage III colorectal cancer patients.
    Yasui K; Shida D; Nakamura Y; Ahiko Y; Tsukamoto S; Kanemitsu Y
    Br J Cancer; 2021 Mar; 124(5):933-941. PubMed ID: 33257844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nomograms for predicting prognostic value of inflammatory biomarkers in colorectal cancer patients after radical resection.
    Li Y; Jia H; Yu W; Xu Y; Li X; Li Q; Cai S
    Int J Cancer; 2016 Jul; 139(1):220-31. PubMed ID: 26933932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of nutritional risk and systemic inflammation with survival in patients with colorectal cancer who underwent curative surgery.
    Nakamura Y; Imada A; Fukugaki A; Kanto S; Yamaura T; Kinjo Y; Kuroda N
    Clin Nutr ESPEN; 2022 Jun; 49():417-424. PubMed ID: 35623847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.